Novartis Appeals US Drug Price Negotiation Loss to Third Circuit

Novartis AG appealed its challenge against the Biden administration’s drug price negotiation plan to the Third Circuit after a lower court rejected its claims that the program violates speech and takes property.

The noticed filed Monday to the US Court of Appeals for the Third Circuit comes after Judge Zahid N. Quraishi of the US District Court for the District of New Jersey on Oct. 18 denied Novartis’ claims that the Medicare Drug Price Negotiation Program takes property, compels speech, and violates the excessive fines clause.

The manufacturer alleged the Centers for Medicare & Medicaid Services’ program violates the First ...